11527016

Source:http://linkedlifedata.com/resource/pubmed/id/11527016

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0018787, umls-concept:C0021467, umls-concept:C0021469, umls-concept:C0032824, umls-concept:C0038766
pubmed:issue	1
pubmed:dateCreated	2001-8-30
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100965718
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Benzamides, http://linkedlifedata.com/resource/pubmed/chemical/HMR 1098, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1472-4472
pubmed:author	pubmed-author:GögeleinHH
pubmed:issnType	Print
pubmed:volume	2
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	72-80
pubmed:dateRevised	2005-11-16
pubmed:meshHeading	pubmed-meshheading:11527016-Adenosine Triphosphate, pubmed-meshheading:11527016-Animals, pubmed-meshheading:11527016-Benzamides, pubmed-meshheading:11527016-Heart, pubmed-meshheading:11527016-Humans, pubmed-meshheading:11527016-Potassium Channel Blockers, pubmed-meshheading:11527016-Potassium Channels, pubmed-meshheading:11527016-Sulfonylurea Compounds
pubmed:year	2001
pubmed:articleTitle	Inhibition of cardiac ATP-dependent potassium channels by sulfonylurea drugs.
pubmed:affiliation	Aventis Pharma Deutschland GmbH, DG Cardiovascular Diseases, Frankfurt/Main, Germany. heinz.goegelein@aventis.com
pubmed:publicationType	Journal Article, Review